Purdue Pharma $7.4bn opioid settlement wins broad support from US states | Business and Economy

The suit, brought by 55 attorneys general, will help compensate victims and fund addiction treatment programmes.

The attorneys general of all 50 US states, Washington, DC, and four US territories have agreed to a $7.4bn settlement with drugmaker Purdue Pharma, the maker of OxyContin – the pain medication that allegedly fuelled a nationwide opioid addiction crisis in the United States.

The group, led by New Jersey Attorney General Matthew Platkin, announced the deal on Monday.

“While we…